NSP International

3 records, newest first. Each line links to the FDA page it came from.

Refusal charges, in plain English

• UNAPPROVED2 refused lines

  Unapproved new drug

  The product appeared to be a new drug within the meaning of section 201(p) of the FD&C Act without an approved New Drug Application. FDA can apply this charge to a food or supplement whose labeling presents it for drug uses.

Questions about NSP International

Is NSP International on an FDA import alert?

No listing for NSP International appears in the FDA import alerts SupplierRadar checked on October 26, 2026. Country-wide alerts may still apply to its products; see the India page.

Has FDA refused shipments from NSP International?

Yes. FDA refused 2 shipment lines from NSP International between August 3, 2020 and January 3, 2023. The most recent, on January 3, 2023, was herbals & botanical teas, n.e.c., charged as UNAPPROVED (unapproved new drug).

Why did FDA refuse NSP International's shipments?

The most frequent charge is UNAPPROVED (unapproved new drug, 2 lines).

When was NSP International last inspected by FDA?

FDA's most recent inspection of NSP International with a final classification is dated August 23, 2018 and was classified NAI (No Action Indicated).

What is NSP International's FEI number?

NSP International's FDA Establishment Identifier (FEI) is 3011469149.